#USA #San Jose, California #Spotline #Veeva Basics #V-Assure

Revolutionizing Biotech Compliance with V-Assure

In a significant stride toward enhancing biotechnological solutions, Spotline, Inc. has announced that Veeva Systems will leverage its V-Assure platform to facilitate expedited pre-validation for Veeva Basics releases. This collaboration marks a pivotal moment in how emerging biotech firms can achieve regulatory compliance more efficiently.

What is Veeva Basics?

Veeva Basics is a comprehensive solution designed specifically for emerging biotech companies, which helps them deploy essential tools rapidly while ensuring built-in GxP (Good Practices) compliance. As the biotech industry continues to grow at an unprecedented pace, the need for efficient validation processes has never been more crucial. Spotline's V-Assure platform addresses this demand directly by streamlining software releases.

Streamlined Release Process

Spotline has played a vital role in expediting the delivery of Veeva Basics through its automation capabilities. The V-Assure platform has successfully automated testing procedures for Veeva's last three releases, focusing on clinical, regulatory, and quality aspects. By automating test cycles, Spotline provides critical documentation that backs the production qualification of Veeva Basics applications.

In detail, the V-Assure platform has empowered the Veeva team in several impactful ways:

• - Automated Test Libraries: Spotline developed reusable, automated test libraries with V-Assure to streamline ongoing validation efforts.
• - Rapid Script Adaptation: The scripts can be quickly adjusted to align with changing release requirements, ensuring that the testing process remains current and efficient.
• - Comprehensive Validation Cycles: Every release undergoes thorough, automated validation cycles, preparing them for audit and inspection right from the get-go.

Steve Harper, General Manager of Veeva Basics, remarked on the partnership's efficiency: “By using Spotline's V-Assure testing platform, we can deliver complete qualification documentation across our Veeva Basics applications. Automating testing helps us to move faster and provide testing and documentation on behalf of our customers, saving time while accelerating delivery.”

The Importance of Automation

Automation in validation processes not only increases efficiency but also mitigates risks associated with manual testing. The V-Assure platform has enabled Veeva to execute over 500 automated test cases across its applications, significantly enhancing the credibility and reliability of their releases.

Sid Sahoo, CEO of Spotline, emphasized the success of this endeavor: “Supporting the Veeva Basics team through three major releases has showcased how automated validation—when done right—can deliver speed and reliability. V-Assure is helping life sciences organizations modernize their validation processes and unlock faster adoption of compliant solutions.”

Upcoming Events: Veeva RD and Quality Summits

Spotline is set to showcase the latest enhancements to V-Assure, including its improved integrations with Veeva Validation Management, at the upcoming Veeva RD and Quality Summits in Europe and the U.S. This event offers an excellent opportunity for industry stakeholders to witness firsthand how V-Assure can transform their validation operations.

Participants are encouraged to schedule demos via Spotline's website to explore how V-Assure can facilitate their validation efforts and drive innovation.

Conclusion

Spotline Inc. is redefining validation and compliance in the biotech sector. By offering pioneering solutions like V-Assure, the company is not just improving the speed of software releases but also ensuring that these processes meet the stringent compliance requirements of the life sciences industry. The future of biotech is here, and it’s powered by automation and innovation through partnerships like that of Spotline and Veeva Systems.